Godavari Drugs Limited (BOM:530317)

India flag India · Delayed Price · Currency is INR
114.53
-3.45 (-2.92%)
At close: Apr 28, 2026
25.05%
Market Cap 951.86M
Revenue (ttm) 986.94M
Net Income (ttm) 36.92M
Shares Out 7.53M
EPS (ttm) 4.91
PE Ratio 25.75
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 4,815
Average Volume 18,832
Open 117.00
Previous Close 117.98
Day's Range 112.31 - 119.00
52-Week Range 69.70 - 129.85
Beta 0.03
RSI 70.71
Earnings Date May 30, 2026

About Godavari Drugs

Godavari Drugs Limited manufactures and sells active pharmaceutical ingredients (APIs), drug intermediaries, and fine chemicals in India. The company offers APIs, including ciprofloxacin HCl, ciprofloxacin lactate, ciprofloxacin betaine, mefenamic acid, enrofloxacin, and elthambutoal HCI; and intermediaries, such as A D lactone for spironolactone and 6 mercaptopurine for azathioprine. It also provides loan licenses and contract manufacturing services for APIs and drug intermediates. The company serves the life science industry. Godavari Drugs L... [Read more]

Industry Pharmaceutical Preparations
Founded 1987
Employees 106
Stock Exchange Bombay Stock Exchange
Ticker Symbol 530317
Full Company Profile

Financial Performance

In fiscal year 2025, Godavari Drugs's revenue was 1.14 billion, a decrease of -27.42% compared to the previous year's 1.57 billion. Earnings were 43.80 million, a decrease of -21.07%.

Financial Statements

News

There is no news available yet.